Cargando…
Structure–Activity Relationship Studies of Tetrahydroquinolone Free Fatty Acid Receptor 3 Modulators
[Image: see text] Free fatty acid receptor 3 (FFA3, previously GPR41) is activated by short-chain fatty acids, mediates health effects of the gut microbiota, and is a therapeutic target for metabolic and inflammatory diseases. The shortage of well-characterized tool compounds has however impeded pro...
Autores principales: | Ulven, Elisabeth Rexen, Quon, Tezz, Sergeev, Eugenia, Barki, Natasja, Brvar, Matjaz, Hudson, Brian D., Dutta, Palash, Hansen, Anders Højgaard, Bielefeldt, Line Ø., Tobin, Andrew B., McKenzie, Christine J., Milligan, Graeme, Ulven, Trond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307922/ https://www.ncbi.nlm.nih.gov/pubmed/32141297 http://dx.doi.org/10.1021/acs.jmedchem.9b02036 |
Ejemplares similares
-
Chemogenetics defines a short-chain fatty acid receptor gut–brain axis
por: Barki, Natasja, et al.
Publicado: (2022) -
Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands
por: Sergeev, Eugenia, et al.
Publicado: (2016) -
Discovery of Potent
Tetrazole Free Fatty Acid Receptor
2 Antagonists
por: Valentini, Alice, et al.
Publicado: (2023) -
Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1
por: Rexen Ulven, Elisabeth, et al.
Publicado: (2018) -
A single extracellular amino acid in Free Fatty Acid Receptor 2 defines antagonist species selectivity and G protein selection bias
por: Sergeev, Eugenia, et al.
Publicado: (2017)